Clinical trial
Use of Optune TTF With Radiation as an Alternative for Elderly Patients With Primary CNS Lymphoma
NCT03530605 is registered in ClinicalTrials.gov with Saint Luke's Health System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Optune TTF With Radiation as an Alternative for Elderly Patients With Primary CNS Lymphoma
- Lead sponsor
- Saint Luke's Health System
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- August 31, 2020
- Completion date
- August 31, 2020
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
central nervous system neoplasms, primary